Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-028178
Filing Date
2021-05-17
Accepted
2021-05-17 07:30:46
Documents
83
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q prtk-10q_20210331.htm   iXBRL 10-Q 1871086
2 EX-1.1 prtk-ex11_422.htm EX-1.1 309910
3 EX-5.1 prtk-ex51_540.htm EX-5.1 7195
4 EX-31.1 prtk-ex311_8.htm EX-31.1 18148
5 EX-31.2 prtk-ex312_6.htm EX-31.2 18312
6 EX-32.1 prtk-ex321_7.htm EX-32.1 6070
7 EX-32.2 prtk-ex322_9.htm EX-32.2 6077
8 GRAPHIC g0iye1r5qeor000001.jpg GRAPHIC 9336
  Complete submission text file 0001564590-21-028178.txt   8297104

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA prtk-20210331.xsd EX-101.SCH 74892
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prtk-20210331_cal.xml EX-101.CAL 46706
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prtk-20210331_def.xml EX-101.DEF 227246
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE prtk-20210331_lab.xml EX-101.LAB 509778
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prtk-20210331_pre.xml EX-101.PRE 382431
14 EXTRACTED XBRL INSTANCE DOCUMENT prtk-10q_20210331_htm.xml XML 1363268
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36066 | Film No.: 21927555
SIC: 2834 Pharmaceutical Preparations